Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SAR125844 is an inhibitor of the receptor tyrosine kinase c-Met (IC50 = 4 nM).1 It is selective for c-Met over tropomyosin-related kinase A (TrkA), TrkB, PDGFRα, Axl, and Mer (IC50s = 39, 280, 55, 87, and 105 nM, respectively).2 SAR125844 inhibits the proliferation of MKN45 gastric cancer cells (IC50 = 7 nM).1 In vivo, SAR125844 (20 mg/kg) inhibits intratumoral c-Met phosphorylation in a MET-amplified Hs 746T gastric cancer mouse xenograft model. SAR125844 (10-45 mg/kg) also reduces tumor volume in Hs 746T and SNU-5 gastric cancer mouse xenograft models.2
WARNING This product is not for human or veterinary use.
1. Discovery and pharmacokinetic and pharmacological properties of the potent and selective MET kinase inhibitor 1-
2. The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-